These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33567318)

  • 1. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program.
    Brophy TJ; Warsavage TJ; Hebbe AL; Plomondon ME; Waldo SW; Rao SV; DeVore AD; Gutierrez JA; Swaminathan RV
    Am Heart J; 2021 May; 235():149-157. PubMed ID: 33567318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET; Williams S; Cronin EM; Blackstone EH; Ellis SG; Roselli EE; Smedira NG; Gillinov AM; Glad JA; Tchou PJ; Szymkiewicz SJ; Chung MK
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction.
    DeVore AD; Yow E; Krucoff MW; Sherwood MW; Shaw LK; Chiswell K; O'Connor CM; Ohman EM; Velazquez EJ
    ESC Heart Fail; 2019 Dec; 6(6):1233-1242. PubMed ID: 31560171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
    Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
    Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
    Kunadian V; Pugh A; Zaman AG; Qiu W
    Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction.
    Park S; Ahn JM; Kim TO; Park H; Kang DY; Lee PH; Jeong YJ; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park SJ; Park DW;
    J Am Coll Cardiol; 2020 Sep; 76(12):1395-1406. PubMed ID: 32943156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology and predictors of major bleeding events in patients with heart failure with reduced ejection fraction undergoing percutaneous coronary intervention.
    Iyer M; Shah R; Zheng W; Ziada KM; Khot U; Krishnaswamy A; Kapadia SR; Reed GW
    Open Heart; 2024 Apr; 11(1):. PubMed ID: 38663889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention.
    Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y
    BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of left ventricular ejection fraction on clinical outcomes after left main coronary artery revascularization: results from the randomized EXCEL trial.
    Thuijs DJFM; Milojevic M; Stone GW; Puskas JD; Serruys PW; Sabik JF; Dressler O; Crowley A; Head SJ; Kappetein AP
    Eur J Heart Fail; 2020 May; 22(5):871-879. PubMed ID: 32043709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
    Kang SH; Lee CW; Baek S; Lee PH; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2017 Jul; 120(1):69-74. PubMed ID: 28483202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
    Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary revascularization for patients with severe left ventricular dysfunction.
    Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
    Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital atherectomy treatment of severely calcified coronary lesions in patients with impaired left ventricular ejection fraction: one-year outcomes from the ORBIT II study.
    Lee MS; Martinsen BJ; Shlofmitz R; Shlofmitz E; Lee AC; Chambers J
    EuroIntervention; 2017 Jun; 13(3):329-337. PubMed ID: 28191873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.
    Yee NP; Siu AM; Davis J; Kao J
    Hawaii J Med Public Health; 2016 Sep; 75(9):273-7. PubMed ID: 27688953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction.
    Bista R; Zghouzi M; Jasti M; Lichaa H; Kerrigan J; Haddad E; Alraies MC; Paul TK
    Curr Cardiol Rep; 2024 May; 26(5):435-442. PubMed ID: 38642298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.